bluebird bio, Inc. (BLUE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for bluebird bio, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.34x | -9.29x | -47.22x | -16.80x | -56.30x | -79.41x |
| P/B Ratio | -2.56x | 10.12x | 55.39x | 36.79x | 25.71x | 48.80x |
| P/S Ratio | 0.96x | 66.76x | 3023.68x | 3759.75x | 138.93x | 1403.56x |
| Profitability | ||||||
| Gross Margin | -6.6% | -13.7% | -180.2% | -961.1% | 97.8% | 93.3% |
| Operating Margin | -322.7% | -828.1% | -6955.4% | -16136.3% | -223.0% | -1817.8% |
| Net Margin | -287.2% | -718.4% | -6403.7% | -22375.2% | -246.8% | -1767.5% |
| EBITDA Margin | -187.1% | -566.7% | -5992.7% | -15208.2% | -220.8% | -1729.7% |
| Liquidity | ||||||
| Current Ratio | 0.48x | 1.41x | 1.27x | 2.20x | 5.97x | 5.15x |
| Quick Ratio | 0.28x | 1.29x | 1.28x | 2.83x | 6.71x | 5.74x |
| Leverage | ||||||
| Debt/Equity | -11.36x | 1.70x | 1.87x | 0.24x | 0.07x | 0.15x |
YoY = year-over-year change. Source: FMP..